Holen Sie sich die Stockscreener-App
42.85
0.40%
0.17
Handel nachbörslich:
42.88
0.03
+0.07%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$42.68
Offen:
$42.52
24-Stunden-Volumen:
3.40M
Relative Volume:
0.66
Marktkapitalisierung:
$11.31B
Einnahmen:
$14.00B
Nettoeinkommen (Verlust:
$1.26B
KGV:
8.7899
EPS:
4.8749
Netto-Cashflow:
$352.00M
1W Leistung:
-3.56%
1M Leistung:
-16.44%
6M Leistung:
-27.00%
1J Leistung:
+36.25%
1-Tages-Spanne:
$42.25
$43.18
1-Wochen-Bereich:
$42.25
$46.13
52-Wochen-Spanne:
$31.45
$84.38
Agilent Technologies Inc Stock (AA) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
412-315-2900
Adresse
201 ISABELLA STREET, PITTSBURGH, PA
Compare AA vs TMO, DHR, NTRA, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AA
Agilent Technologies Inc
|
42.85 | 11.31B | 14.00B | 1.26B | 352.00M | 4.8749 |
TMO
Thermo Fisher Scientific Inc
|
675.00 | 249.58B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
224.49 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
412.56 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.79 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
270.37 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Agilent Technologies Inc Stock (AA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-09 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2026-03-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-27 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2026-01-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-01-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-08 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-08 | Fortgesetzt | Citigroup | Buy |
| 2025-05-15 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-08 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-10-23 | Hochstufung | Argus | Hold → Buy |
| 2024-10-17 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-10-01 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-09-25 | Fortgesetzt | JP Morgan | Neutral |
| 2024-09-04 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-08-12 | Hochstufung | UBS | Sell → Buy |
| 2024-08-02 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2024-06-21 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-04-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-01-16 | Eingeleitet | UBS | Sell |
| 2023-12-07 | Eingeleitet | HSBC Securities | Hold |
| 2023-10-23 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-07-24 | Herabstufung | Argus | Buy → Hold |
| 2023-07-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-07-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2023-06-22 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-05-11 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-05-08 | Eingeleitet | JP Morgan | Overweight |
| 2023-02-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-01-19 | Bestätigt | B. Riley Securities | Neutral |
| 2022-12-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-07 | Eingeleitet | UBS | Neutral |
| 2022-09-22 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-09-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-08 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-03-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-11 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-11-17 | Eingeleitet | Wolfe Research | Outperform |
| 2021-11-02 | Hochstufung | Jefferies | Hold → Buy |
| 2021-10-05 | Bestätigt | JP Morgan | Overweight |
| 2021-09-29 | Bestätigt | Morgan Stanley | Overweight |
| 2021-09-15 | Hochstufung | Argus | Hold → Buy |
| 2021-07-16 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-04-23 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-24 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-03-17 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-03-03 | Hochstufung | Goldman | Sell → Buy |
| 2020-09-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-03-24 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2020-03-04 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2020-01-17 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-12-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-13 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-11-12 | Bestätigt | B. Riley FBR | Buy |
| 2019-11-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-10-21 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2019-09-26 | Bestätigt | B. Riley FBR | Buy |
| 2019-09-23 | Herabstufung | Goldman | Buy → Neutral |
| 2019-09-11 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-08-16 | Bestätigt | BofA/Merrill | Neutral |
| 2019-07-19 | Herabstufung | Argus | Buy → Hold |
| 2019-07-11 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-07-09 | Herabstufung | Macquarie | Outperform → Neutral |
| 2019-04-22 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2019-04-03 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-04-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
Alle ansehen
Agilent Technologies Inc Aktie (AA) Neueste Nachrichten
Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story - Yahoo Finance
Agilent Technologies stock trades at USD 172.68 near its 52-week high - AD HOC NEWS
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Agilent Technologies stock gains 3.9 percent ahead of the open - AD HOC NEWS
Agilent Technologies Inc (A) Shares Surge 4.5% -- What GF Score of 93 Tells Investors - GuruFocus
Form 8K Agilent Technologies For: 24 September By Investing.com - Investing.com Canada
Why Agilent Technologies (A) Stock Is Up Today - moomoo.com
Agilent Technologies stock hits 52-week high at 169.07 USD - Investing.com
Agilent Technologies stock reports 8.1 percent revenue growth - AD HOC NEWS
AGILENT TECHNOLOGIES, INC. SEC Filing (Sep 24, 2026) - Stock Titan
Agilent Technologies stock slips before the bell - AD HOC NEWS
If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now - Eastern Progress
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation - TradingView
Agilent Technologies Analysis: 3.29% Surge Highlights Strong Momentum - The Cryptonomist
Agilent Technologies at U.S. All Stars Conference: growth broadens By Investing.com - Investing.com Canada
Agilent Technologies at U.S. All Stars Conference: growth broadens - Investing.com
Why Did Agilent Technologies (A) Shares Climb After Its Latest Update? - simplywall.st
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Technologies price pierces price targetForecast today22-09-2026 - Economies.com
Agilent Technologies stock gains 3.3 percent on strong results - AD HOC NEWS
Research Tools & Consumables Stocks Q2 Highlights: Agilent (NYSE:A) - TradingView
Agilent Technologies stock heads into the open after a 3.3% gain - AD HOC NEWS
Agilent Technologies Inc (A) Stock Up 3.5% but GF Value Says Ove - gurufocus.com
Agilent Technologies Inc (A): GF Score of 96 Signals Strong Outp - gurufocus.com
Agilent Technologies stock gains on TapeStationDx launch and raised EPS guidance - AD HOC NEWS
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control - BioSpace
Agilent launches clinical lab systems for DNA, RNA analysis By Investing.com - Investing.com Nigeria
Goldman Sachs Maintains Agilent Technologies(A.US) With Buy Rating, Raises Target Price to $185 - moomoo.com
Agilent launches clinical lab systems for DNA, RNA analysis - Investing.com
Goldman Sachs Adjusts PT on Agilent Technologies to $185 From $175, Maintains Buy Rating - moomoo.com
Agilent Technologies, Inc. (A) Stock Analysis: Unveiling a 11.81% Potential Upside in Diagnostics & Research - DirectorsTalk Interviews
Agilent Technologies stock heads into the open after a modest gain - AD HOC NEWS
Agilent Technologies stock rises on August 26 guidance lift - AD HOC NEWS
Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time - Yahoo Finance
Agilent Technologies stock gains on fresh scanner launch and dividend - AD HOC NEWS
Is FDA Cleared Scanner Launch Altering The Investment Case For Agilent Stock? - simplywall.st
Agilent Technologies Inc. 2017 Q3ResultsEarnings Call Slides (NYSE:A) 2017-08-15 - Seeking Alpha
Agilent Technologies stock trades steadily as investors weigh recent earnings and margin outlook - AD HOC NEWS
Agilent Technologies, Inc. (1A.MI) Analyst insights, Price targets and RecommendationsYahoo Finance - Yahoo Finance Singapore
Agilent Technologies, Inc. (A) Stock Forecasts - Yahoo Finance
Agilent Technologies To Go Ex-Dividend On October 6th, 2026 With 0.255 USD Dividend Per Share - moomoo.com
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share - Yahoo Finance
Agilent Technologies Keeps Quarterly Dividend at $0.255 per Share - marketscreener.com
Agilent declares quarterly dividend of 25.5 cents per share - Investing.com
Press Release: Agilent Announces Cash Dividend of 25.5 Cents per Share - 富途牛牛
Agilent Technologies, Inc. (A) Stock Analysis: Exploring A 19% Upside Potential - directorstalkinterviews.com
Jefferies Initiates Agilent Technologies(A.US) With Hold Rating, Announces Target Price $155 - Moomoo
Agilent Technologies stock edges lower as analysts keep upside targets - ad-hoc-news.de
Agilent Technologies stock heads into the open after a 1.2 percent drop - ad-hoc-news.de
Agilent to Participate in J.P. Morgan U.S. All Stars Conference - Finviz
Agilent’s CEO and CFO will join a London fireside chat Sept. 23 - Stock Titan
Finanzdaten der Agilent Technologies Inc-Aktie (AA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
1.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):